Healthcare Associated Infections (HAI)

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Richard Haupt, MD, MPH, discusses the process for developing a vaccine.

One intensive care unit utilized advanced infection control efforts to tackle an outbreak and won.

A surprising source of this opportunistic pathogen was found through environmental testing.

Dr. Richard Vickers explains how recurrent infection is an unmet medical need when it comes to C. difficile.

Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.

Authors of a new Policy Forum suggest an alternative approach to regulating fecal microbiota transplantation.

Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Here are a few things your friendly infection control team would appreciate for the holidays.

Dr. Richard Vickers explains how antibiotics to treat Clostridium difficile infection cause collateral damage to the gut microbiome.

A team of investigators explores if fecal microbiota transplant (FMT) capsules are just as effective as treatment via colonoscopy.

The Society for Healthcare Epidemiology of America (SHEA), with support from the Centers for Disease Control and Prevention (CDC), released new expert guidance to help hospitals prepare for and contain infectious disease outbreaks.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Richard Haupt, MD, MPH, explains how a vaccine can serve as a primary prevention modality against C. difficile.

The FDA has cleared the molecular test which is able to detect presence of the toxin within 70 minutes.

Many US Governors have signed a state proclamation proclaiming November 2017 as Clostridium difficile Infection Awareness Month,

Richard Haupt, MD, MPH, explains why a vaccine to help prevent C. difficile is so needed.

Check out the third portion of our exclusive interview with Maureen Spencer, Accelerate Diagnostics, as we discuss how reducing antibiotics could be key to preventing C. difficile infections.

New research finds that ineffective empiric treatment can lead to deadly consequences in late-onset sepsis patients.

Maureen Spencer, Accelerate Diagnostics, sat down with Contagion® to discuss the challenges of disinfecting hospital rooms to prevent C. difficile.